Defibtech

Guilford, United States Founded: 1999 • Age: 27 yrs Acquired By Nihon Kohden
AEDs and resuscitation products are designed and manufactured.

About Defibtech

Defibtech is a Healthcare company based in Guilford (United States) founded in 1999, and was acquired by Nihon Kohden in October 2012. AEDs and resuscitation products are designed and manufactured. Its chief executive, as recorded, is Robert Reinhardt. Its website defibtech.com draws about 15 thousand monthly visits. Defibtech offers products and services including AEDs and ACC Devices. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is DEFIBTECH, LLC. Its competitors include CVRx, Adona Medical and Element Science; 3 of its 3 listed competitors have raised funding.

Company details

Defibtech was established in 1999 in Guilford, United States, within the medical devices sector. Automated external defibrillators (AEDs) and related resuscitation equipment, including the Lifeline ARM automated chest compression device, are developed and produced. Product lines encompass the Lifeline and ReviveR AED families, along with accessories. An AED model equipped with a full-color video display for instructional guidance on emergency procedures is provided.

Key Metrics

Products & Services of Defibtech

Defibtech offers a comprehensive portfolio of products and services, including AEDs and ACC Devices.

AEDs
Defibrillators

Devices for treating sudden cardiac arrest in public settings.

ACC Devices
Chest Compression Tools

Mechanical aids for delivering CPR to patients in cardiac arrest.

Investors in Defibtech

Defibtech has secured backing from 1 investor. Prominent investors backing the company include Nihon Kohden.

All
InvestorDescriptionFounded YearDomainLocation
Manufacturer, Exporter, importer and Supplier of Medical equipment
1951nihonkohden.comTokyo, Japan
Premium access

Investor details for Defibtech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Defibtech

27 people are tracked at Defibtech (11 in leadership, 16 in team).

NameRoleGroup
Robert Reinhardt
CEO & PresidentLeadership
Christopher Scheibel
Director Financial Planning And AnalysisLeadership
Matt Valentine
Senior Vp, Research & DevelopmentLeadership
Kenneth Kanzler
Chief Financial Officer And Local Compliance OfficerLeadership
Melissa Johnston
Director Of MarketingLeadership
Matt Fahy
Senior Vice President, Product MarketingLeadership
Robert Jamieson
VP QA / RALeadership
David Hicks
Director, Advanced DevelopmentLeadership
Michael Hicks
Director Of Software DevelopmentLeadership
Brian Kunzeman
Senior Vice President, OperationsLeadership
Jassa Canth
Director Of OperationsLeadership
Charlie Chacko
Senior Product Development ManagerTeam
Ashleigh Simpson
Inventory Control ManagerTeam
Roy Abrams
Senior Mechanical EngineerTeam
Jason Alderete
Senior Design Quality EngineerTeam
Gregory T. Norrie
Engineering TechnicianTeam
Kaitlyn Heller
Senior System EngineerTeam
Christopher Rivera
Senior Design Quality EngineerTeam
Jeffrey Watson
Validation EngineerTeam
Geoff Knees
Eng Services MgrTeam

7 more people are available in the full profile.

Premium access

Complete people profiles for Defibtech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Defibtech

2 dated milestones of Defibtech across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Defibtech is founded.
  2. Exit Acquired by Nihon Kohden.

Competitors of Defibtech

Defibtech has 3 listed competitors in our database, 3 of them funded. They include CVRx, Adona Medical and Element Science.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cvrx.com2001Minneapolis, United States$368.5M142
Implantable technology for hypertension and heart failure is developed.
adonamed.com2017Campbell, United States$71M
Medical devices for heart failure management are developed.
elementscience.com2013San Francisco, United States$192.6M
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
Premium access

Detailed competitors of Defibtech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Defibtech

The website of Defibtech (defibtech.com) receives about 15.2K visits a month.

  • Monthly visits
    15.2K

    ▼ 6.2% vs previous month

Similar websites

Websites whose visitors overlap most with Defibtech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ambu.com
100%
75.4K#470,760View details
heartsine.com
100%
5.5K#3,549,156View details
emedcert.com
emedcert.com
93%
#952,796–
accessmedical.com
accessmedical.com
90%
–
eworldpoint.com
eworldpoint.com
87%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 15 similar websites and full traffic analytics for Defibtech

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Defibtech (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Defibtech

Premium access

Complete news archive for Defibtech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Defibtech

Defibtech was founded in 1999.

Defibtech is headquartered in Guilford, United States. It is registered at Guilford, Connecticut, United States.

Robert Reinhardt is the CEO of Defibtech, as recorded in our data.

Defibtech was established in 1999 in Guilford, United States, within the medical devices sector. Automated external defibrillators (AEDs) and related resuscitation equipment, including the Lifeline ARM automated chest compression device, are developed and produced. Product lines encompass the Lifeline and ReviveR AED families, along with accessories. An AED model equipped with a full-color video display for instructional guidance on emergency procedures is provided.

Defibtech's top competitors include CVRx, Adona Medical and Element Science.

Defibtech offers AEDs and ACC Devices.

Defibtech has 1 investor. Key investors include Nihon Kohden.

Defibtech operates through Defibtech, Llc.

Yes. Defibtech was acquired by Nihon Kohden in October 2012.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available